SightfileU.S. market data from official filings

RADNET INC (RDNT)

Name: RADNET INC (RDNT) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000790526 · EDGAR filings · Updated 2026-06-22

RADNET INC (RDNT) has reported institutional ownership of 99.3%, with 339 institutional managers holding positions valued at $4.31B per the latest 13F reporting period.

Institutional ownership

99.3%

Institutional managers

339

Reported 13F value

$4.31B

Insider activity

73 trans.

−$28.0M net selling

Latest updates

2026-06-22 — Insider transaction reported (Form 4)
2026-06-18 — Insider transaction reported (Form 4)
2026-06-18 — Insider transaction reported (Form 4)
2026-06-18 — Notice of proposed sale filed (Form 144)
2026-06-16 — Notice of proposed sale filed (Form 144)
2026-06-16 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, RADNET INC has 339 institutional holders and institutional ownership of 99.3%.

Insider activity

Insiders reported 73 transactions (0 buys, 27 sells) across 14 reporting insiders, with a net reported value of −$28.0M.

Related companies

CRINETICS PHARMACEUTICALS IN (CRNX) · OPTION CARE HEALTH INC (OPCH) · ERASCA INC (ERAS) · IRHYTHM HOLDINGS INC (IRTC) · SPYRE THERAPEUTICS INC (SYRE) · LIGAND PHARMACEUTICALS INC (LGND)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-22.